Pemvidutide Shows Sustained Weight Loss and Liver Improvement in Extended MASH Trial Data
- January 9, 2026
CRISPR Therapeutics Shares Promising Updates on Zugo-cel in Autoimmune and Oncology Trials
FDA Approves Amneal’s Denosumab Biosimilars Boncresa and Oziltus
Risk-Based Breast Cancer Screening Shows Promise in Major U.S. Study
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
For #FactFriday, we're highlighting Thyroid Eye Disease—an autoimmune condition that affects the eyes and can impact quality of life. Learn these important facts about TED and help spread awareness! #thyroideyedisease #TED #PatientWorthy
#shareyourstory with us here: bit.ly/4dV7gru
Pemvidutide Shows Sustained Weight Loss and Liver Improvement in Extended MASH Trial Data bit.ly/3YVjFoy Read now at PatientWorthy.com
#PatientWorthy #Mash #metabolicdysfunction-AssociatedSteatohepatitis #clinicaltrials
#liverdisease #itching #RareDisease
This content isn't available right now
When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.
